Why post-close integration may decide animal health deals: full analysis

A May 1 commentary in Animal Health News and Views makes a simple point with broad implications for veterinary business leaders: once an acquisition closes, the real risk may be losing the people and operating habits that created the target’s value. Writing from the animal health side of the industry, Deven Vespi argues that buyers often pay for products, approvals, contracts, and revenue, then move too quickly to standardize the acquired company, weakening the relationships and judgment that made those assets productive. (animalhealthnewsandviews.com)

Vespi builds that case through two anonymized examples. In one, a founder-led animal health company was acquired, its CEO stayed through transition, and then key leaders in regulatory affairs, formulation science, and commercial operations exited soon after close. Vespi writes that competitors quickly moved to recruit talent from the destabilized team, and the business then spent more than four years trying to recover from a stalled pipeline, weaker client relationships, and lower output. In the second example, a smaller company retained most of its systems and products after acquisition, but not its main salesperson, and the business was shut down within two years. (animalhealthnewsandviews.com)

The broader framework behind that argument is well established in M&A literature. In their 2011 Harvard Business Review article “The New M&A Playbook,” Clayton Christensen, Richard Alton, Curtis Rising, and Andrew Waldeck wrote that companies spend more than $2 trillion annually on acquisitions, yet studies have put the failure rate between 70% and 90%. Their core point was that acquirers often misunderstand what they are really buying, especially when value depends not just on transferable resources, but on embedded processes and values. Vespi applies that logic directly to animal health, where regulatory pathways, distributor trust, and practice-facing commercial relationships are often highly person-dependent. (hbs.edu)

That interpretation also lines up with academic work on integration strategy. Julia Bodner and Laurence Capron’s 2018 review of post-merger integration describes the “autonomy-coordination dilemma,” or the tension between preserving what makes an acquired company distinctive and integrating it enough to capture synergies. Earlier work by Julian Birkinshaw, Henrik Bresman, and Lars Håkanson found that human integration and task integration interact in value creation, suggesting that trust, cultural understanding, and relationship continuity can’t simply be treated as secondary to systems integration. Vespi’s central criticism is that many buyers invert that sequence, integrating org charts and reporting lines first, and dealing with people later. (link.springer.com)

There doesn’t appear to be a separate press release or company announcement tied to Vespi’s article; it reads as an industry viewpoint rather than a report on a specific disclosed transaction. Still, its timing fits a market where succession, consolidation, and integration remain active themes across animal health. Recent sector examples have included leadership-transition announcements such as Phibro Animal Health’s December 18, 2025, 8-K outlining a planned July 1, 2026, CEO handoff from Jack Bendheim to Dani Bendheim, with continuity built into the transition structure. That kind of formal planning is different from the anonymized cases Vespi describes, but it highlights the same issue: who stays, who leads, and how continuity is protected after a major corporate change. (stocktitan.net)

For veterinary professionals, the article’s practical relevance goes beyond corporate dealmaking. AAHA has reported persistent retention concerns across clinical practice, including findings from its retention research showing that a meaningful share of veterinary professionals were considering leaving their current roles and that teamwork, appreciation, and culture rank among the most important drivers of staying. In other words, the same conditions that make a practice vulnerable to ordinary turnover can make an acquired business especially vulnerable during integration. If a hospital group, distributor-facing company, or specialty service business loses the people who carry trust with clinics, referral partners, or field teams, the impact can show up quickly in service consistency and revenue durability. (aaha.org)

Why it matters: Vespi’s piece is really a warning about invisible assets. In veterinary medicine and animal health, value often sits in regulatory memory, long-standing distributor ties, KOL access, territory knowledge, and the credibility individual team members have built with veterinarians and pet parents over time. Those assets don’t always transfer cleanly in a purchase agreement. For buyers, that raises the importance of naming key people early, building retention terms into deal structure, and slowing down integration where relationships are the product. For sellers, it suggests that post-close governance, operational autonomy, and leadership continuity deserve more attention during negotiations than they often get. (animalhealthnewsandviews.com)

What to watch: The next signal to watch is whether veterinary and animal health acquirers get more explicit about retention, transition governance, and phased integration, rather than treating those as back-end HR issues. If they do, post-close performance may become less about headline deal value and more about whether the people who hold the business together choose to stay. (animalhealthnewsandviews.com)